Kovitz Investment Group Partners’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.7K Hold
19,201
﹤0.01% 1343
2025
Q1
$26.1K Hold
19,201
﹤0.01% 1227
2024
Q4
$72.9K Hold
19,201
﹤0.01% 1202
2024
Q3
$51.8K Buy
+19,201
New +$51.8K ﹤0.01% 1002